ArticleScientific reports2026

Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotype.

Yoshiko Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.